Here’s Why Exact Sciences (EXAS) Landed in RiverPark’s Detractor List
RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Exact Sciences Corp (EXAS)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 11,728,629 | $1,119,498 | +10% | 2.68% |
| 2. | Casdin Capital Eli Casdin | 2,360,186 | $225,280 | 5.6% | |
| 3. | Zevenbergen Capital Investments Nancy Zevenbergen | 1,741,413 | $166,218 | -4% | 3.15% |
| 4. | Eminence Capital Ricky Sandler | 1,414,213 | $134,987 | +29% | 1.82% |
| 5. | 84,950,000 | $91,562 | -13% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.71 | 2,500 | Director | 60,858 | 2017-08-17 | Filing | |
| $13.84 | 10,000 | Director | 136,379 | 2016-12-14 | Filing | |
| $18.10 | 5,000 | Director | 121,247 | 2016-09-01 | Filing | |
| $17.93 | 3,380 | Director | 105,927 | 2016-08-03 | Filing | |
| $5.38 | 3,775 | Director | 91,000 | 2016-03-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $93.88 | 16,922 | Officer, Director | 664,380 | 2021-11-01 | Filing | |
| $93.64 | 17,078 | Officer, Director | 681,302 | 2021-10-01 | Filing | |
| $104.42 | 18,978 | Officer, Director | 698,380 | 2021-09-01 | Filing | |
| $107.50 | 19,970 | Officer, Director | 717,358 | 2021-08-02 | Filing | |
| $111.11 | 1,381 | Director | 34,741 | 2021-07-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 612,416 | $58,455,107 | 0.02% | |
| 2. | 27,526,000 | $29,550,813 | 0.04% | |
| 3. | 24,750,000 | $26,542,890 | 0.01% | |
| 4. | 205,522 | $19,617,075 | 0.22% | |
| 5. | 12,288,000 | $17,968,374 | 0.02% |
News See All
Here’s Why Artisan Partners Reduced its Exact Sciences Corp. (EXAS) Position
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ third quarter 2021 investor letter – a copy of which can be downloaded here.
11 Best Genomic Stocks to Buy Now
Genomics is a branch of biology that studies the structure, function, evolution, mapping, and editing of genomes, which refer to the complete set of DNA of an organism, as opposed to genetics, which is...
Should I Avoid EXACT Sciences Corporation (EXAS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Exact Sciences (EXAS), A Top Detractor in RiverPark’s Q2 Results
RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
10 Reddit’s WallStreetBets Stocks That are Tumbling
In this article, we discuss the 10 Reddit's WallStreetBets stocks that are tumbling.
EXACT Sciences Corporation (EXAS): Are Hedge Funds Right About This Stock?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
10 Best Biotech Stocks to Buy According to Cathie Wood
In this article we will take a look at the 10 best biotech stocks to buy according to Cathie Wood.
5 Best Biotech Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best biotech stocks to buy according to Cathie Wood.
10 Best Stocks to Buy in 2021 According to Cathie Wood
In this article we will take a look at the 10 best stocks to buy in 2021 according to Cathie Wood.
Billionaire Hedge Funds
